| Literature DB >> 32489333 |
Xufeng Fu1,2, Bo Xu1, Jiang Jiang3, Xing Du1, Xiaoli Yu1, Yaping Yan2, Shanshan Li2, Briauna Marie Inglis2, Huiming Ma1, Hongyan Wang1, Xiuying Pei1, Wei Si2.
Abstract
BACKGROUND: Human umbilical cord-derived MSCs (hUC-MSCs) have been identified as promising seeding cells in tissue engineering and clinical applications of regenerative medicine due to their advantages of simple acquisition procedure and the capability to come from a young tissue donor over the other MSCs sources. In clinical applications, large scale production is required and optimal cryopreservation and culture conditions are essential to autologous and allogeneic transplantation in the future. However, the influence of cryopreserved post-thaw and long-term culture on hUC-MSCs remains unknown, especially in terms of specific protein expression. Therefore, biological characteristics and proteomic profiles of hUC-MSCs after cryopreserving and long-term culturing were investigated.Entities:
Keywords: Cryopreservation; Human umbilical cord; Long-term culture; Mesenchymal stem cells; Proteomic analysis
Year: 2020 PMID: 32489333 PMCID: PMC7247169 DOI: 10.1186/s12014-020-09279-6
Source DB: PubMed Journal: Clin Proteomics ISSN: 1542-6416 Impact factor: 3.988
Fig. 1A schematic illustration of the procedure for hUC-MSCs cryopreservation and long-term culture. LN2: liquid nitrogen. P4N24: non-cryopreserved and sub-cultured for 24 h at P4. P4C24: cryopreserved and sub-cultured for 24 h at P4, P4N48: non-cryopreserved and sub-cultured for 48 h at P4, P4C48: cryopreserved and sub-cultured for 48 h at P4, P10N24: non-cryopreserved and sub-cultured for 24 h at P10, P10C24: cryopreserved and sub-cultured for 24 h at P10, P10N48: non-cryopreserved and sub-cultured for 48 h at P10, P10C48: cryopreserved and sub-cultured for 48 h at P10
Fig. 2Fibroblast-like morphology of MSCs at passage 0 (a) and passage 3 (b). Scale bars: 100 μm. c–g Surface markers expression on human umbilical cord-derived MSCs at passage 3 analyzed using flow cytometry. Black lines represent isotype control. h Quantitative profile of surface markers expression (n = 3). i–k Differentiation potency of MSCs at passage 3. i Adipogenic differentiation (oil red staining, × 200); j Osteogenic differentiation (alizarin red staining, × 100); k Chondrogenic differentiation (alcian blue staining, × 50). Scale bars: i was 50 μm, j was 100 μm and k was 500 μm
Fig. 3Comparison of the cell viability (n = 3) (a), surface markers expression (n = 3) (b) and morphology (c) between non-cryopreserved (N) and cryopreserved (C) groups after being sub-cultured for 24 h or 48 h at P4 and P10, respectively
Fig. 4Comparison of adipogenic (a), osteogenic (b) and chondrogenic (c) differentiation potency between non-cryopreserved (N) control and cryopreserved (C) groups after being sub-cultured for 24 h or 48 h at P4 and P10, respectively
Fig. 5The number and the GO heatmaps of differentially expressed proteins. a The histogram of differentially expressed proteins. The heatmap of differential proteins enriched pathways in molecular function (b), biological process (c), cellular component (d) and protein domain (e)
Biological processes classification of differential identified proteins in MSCs
| Biological processes | Gene name |
|---|---|
| Differentiation | GATA6, DKK1, STC1, PDGFRB, COL5A2, FST, CCNB1, AURKA, TOP2A, INHBA, COL1A1, ANLN, JUN, SEMA7A, NCAM1, COL12A1, NRP2, FBN2, HGF |
| Immune system regulation process | TNFAIP3, KIF2C, PTX3, TMBIM1, IGHG1, JUN, NDRG1, NCAM1, MYO10, KIF22, COL1A1, RACGAP1, SEMA7A, KIF11, INHBA, MT2A, FST, C3, GEM, TOP2A, SERPINE1, KIF23, ANLN, PDCD1LG2, CRISPLD2, JUN |
| Wound healing and regeneration | TNFAIP3, SERPINB2, GATA6, MKI67, SERPINE1, F3, FOSL1, AURKA, COL1A1, DCN, NRP2, HGF, JUN, C3, PDGFRB, CCNB1, TFPI2, HIST2H3A, CCNA2 |
| Apoptotic signaling pathway | BIRC5, STK17B, F3, TNFAIP3, SERPINE1, INHBA, TMBIM1, TIMP3, TOP2A, CHEK1, HGF, PDGFRB, TPX2, GATA6, SERPINB2, AURKA, CCNB1, TNFAIP3, NUAK1, FOSL1, AURKB, CPEB4, PLK1, JUN, ARAF, AMIGO2 |
| Myeloid cell differentiation and ossification | INHBA, FBN2, STC1, COL5A2, JUN, HGF, COL1A1, SEMA7A |
| Oxidation resistance | TNFAIP3, PTX3, NDRG1, TIMP3, SERPINE1, COL1A1, NDRG1, STK17B,AURKA, PLK1, PDGFRB, CPEB4, AURKB, AMIGO2, TMBIM1, JUN, STC1, ARAF, GATA6, HGF, FOSL1, CCNB1, TOP2A, F3, CPEB4, BIRC5, SERPINB2, INHBA, CCNA2 |
| Adaptive immune response | TNFAIP3, IGHG1, MYO10, DCN, C3, HGF, PDCD1LG2, JUN, SEMA7A, FST, INHBA, PTX3, TOP2A, SERPINE1, NCAM1, ANLN, MT2A |
| Inflammatory response | TNFAIP3, PTX3, SERPINE1, PDCD1LG2, SEMA7A, F3, HGF, C3 |
| Interferon-gamma-mediated signaling pathway | PDCD1LG2, NCAM1, INHBA, MT2A |
| Cartilage development | STC1, BNC2, LUM, COL1A1, STC1, COL1A1, MEX3C |
| Regulation of cytokine production | GATA6, LUM, TNFAIP3, SERPINE1, PDCD1LG2, SEMA7A, INHBA, HGF, C3 |
| Angiogenesis | SERPINE1, GATA6, PDGFRB, F3, JUN, HGF, NRP2, C3 |
| Antigen processing and presentation | RACGAP1, TNFAIP3, CCNA2, KIF22, INHBA, KIF11, KIF2C, KIF23 |
| Cell migration | F3, STC1, SERPINE1, SMURF2, DCN, COL1A1, PDGFRB, HGF, NRP2, JUN |
| Transforming growth factor beta1 production | GATA6, COL1A1, C3, LUM, JUN, SERPINE1, TNFAIP3, PDCD1LG2, SEMA7A, HGF, INHBA |
| Response to growth factor | PDGFRB, GATA6, NRP2, DKK1, SHCBP1, SHCBP1, CCNA2, SMURF2, COL1A1, SMURF2, JUN, FBN2, HGF, DCN, LUM |
| Aging | CHEK1, SERPINE1, AURKB, PDGFRB, DCN, JUN |
| Regulation of endothelial cell proliferation | SERPINE1, GATA6, DCN, TNFAIP3, THBS2, HGF, F3, C3, JUN, NRP2 |
Differential proteins associated with MSCs function
Red is up-regulation and blue is down-regulation, NS is no significant difference
Fig. 6Heatmap of pathways (a) and differentially expressed proteins (b) enriched according to KEGG database among the eight groups
Comparison of the quantification results between TMT and PRM of the 14 candidate different expression proteins
| Protein accession | Proteins | Signature peptides | P4N24/P4C24 | P4N24/P10N24 | P4C24/P10C24 | P10N24/P10C24 | ||||
|---|---|---|---|---|---|---|---|---|---|---|
| TMT | PRM | TMT | PRM | TMT | PRM | TMT | PRM | |||
| Q8IVL6 | P3H3 | DLETPPHWAAYDTGLELLGR | 1.03 | 1.17 | 0.96 | 1.06 | 0.91 | 0.86 | 0.98 | 0.96 |
| P53814 | SMTN | AQEIEAATLAGRLQDGTPQAALSPLTPAR | 1.04 | 1.04 | 1.23 | 1.27 | 1.92 | 3.29 | 1.63 | 2.68 |
| Q96CG8 | CTHRC1 | QCSWSSLNYGIDLGKVLFSGSLR | 1.47 | 2.08 | 0.89 | 0.81 | 0.61 | 0.39 | 1.01 | 1.00 |
| O75326 | SEMA7A | DPYCGWDQGR | 1.06 | 1.09 | 1.10 | 1.08 | 1.70 | 3.03 | 1.64 | 3.08 |
| P35354 | PTGS2 | SHLIDSPPTYNADYGYKSGLDDINPTVLLK | 1.40 | 2.79 | 0.57 | 0.50 | 0.81 | 0.53 | 2.00 | 2.99 |
| Q9NQW6 | ANLN | LLLIATGKGFLTIFEDVSGFGAWHR | 1.06 | 1.08 | 1.36 | 1.32 | 1.71 | 2.44 | 1.34 | 1.99 |
| P58335 | ANTXR2 | VSPVGETYIHEGLKLDALWALLR | 0.87 | 0.97 | 0.75 | 0.70 | 1.18 | 1.17 | 1.36 | 1.63 |
| P48307 | TFPI2 | LQVSVDDQCEGSTEKTCDAFTYTGCGGNDNNFVSR | 1.08 | 0.96 | 0.66 | 0.47 | 1.20 | 1.23 | 1.98 | 2.51 |
| Q13642 | FHL1 | FWHDTCFR | 1.56 | 1.45 | 2.06 | 2.00 | 1.69 | 2.53 | 1.28 | 1.84 |
| Q02241 | KIF23 | ALLQEFDNAVLSK | 0.96 | 1.05 | 1.29 | 1.49 | 1.59 | 1.82 | 1.18 | 1.28 |
| Q9H0H5 | RACGAP1 | SIGSAVDQGNESIVAK | 0.97 | 0.87 | 1.25 | 1.56 | 1.50 | 2.47 | 1.17 | 1.38 |
| P53350 | PLK1 | LILYNDGDSLQYIER | 0.96 | 1.01 | 1.27 | 1.89 | 1.68 | 2.70 | 1.27 | 1.44 |
| P00749 | PLAU | FEVENLILHK | 0.62 | 0.42 | 0.43 | 0.27 | 1.23 | 1.50 | 1.76 | 2.30 |
| O00762 | UBE2C | GISAFPESDNLFKLSLEFPSGYPYNAPTVK | 1.02 | 1.05 | 1.27 | 1.52 | 1.63 | 2.06 | 1.31 | 1.42 |